Alexander P. Davis
119-143 Missenden Road
Camperdown, VIC 2050, Australia
Camperdown, VIC 2050, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Real-World outcomes of Non-Small cell lung cancer patients harbouring KRAS G12C and KRAS G12D mutations.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: January 30, 2025
An Update on Emerging Therapeutic Options for Malignant Pleural Mesothelioma.
Journal: Lung Cancer (Auckland, N.Z.)
Published: August 24, 2021
Asbestos-related lung cancer: Clinical characteristics and survival outcomes in an Australian cohort seeking workers compensation.
Journal: Asia-Pacific journal of clinical oncology
Published: August 03, 2021
Efficacy of immunotherapy in KRAS-mutant non-small-cell lung cancer with comutations.
Journal: Immunotherapy
Published: June 11, 2021
Emerging biological therapies for the treatment of malignant pleural mesothelioma.
Journal: Expert opinion on emerging drugs
Published: May 04, 2021
Relationship between PD-L1 expression and outcome in EGFR-mutant lung cancer patients treated with EGFR tyrosine kinase inhibitors.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: October 17, 2020
Prolonged Disease Control on Nivolumab for Primary Pulmonary NUT Carcinoma.
Journal: Clinical lung cancer
Published: July 13, 2020
Australian experience of peptide receptor radionuclide therapy in lung neuroendocrine tumours.
Journal: Oncotarget
Published: May 09, 2020
COVID-19: the use of immunotherapy in metastatic lung cancer.
Journal: Immunotherapy
Published: May 01, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026